BSVN Form 4: CEO Travis Thomas Sells 13,084 Shares; Retains 286,293
Rhea-AI Filing Summary
Travis Thomas L, President & CEO and director of Bank7 Corp. (BSVN), reported a sale of 13,084 shares of common stock on 08/26/2025 at a weighted-average price of $49.3566. After the sale, he beneficially owns 286,293 shares. The filing notes that the sale occurred in multiple transactions with prices ranging from $49.16 to $49.55. The reported holdings include several restricted stock unit (RSU) balances that vest on specified future dates, with detailed vesting schedules disclosed for multiple grants. No derivative transactions were reported.
Positive
- Reporting person retains a substantial stake of 286,293 shares after the sale, signaling ongoing alignment with shareholders
- Clear disclosure of weighted-average sale price and price range ($49.16 to $49.55) enhances transparency
Negative
- Insider sold 13,084 shares, a near-term reduction in the reporting person's direct holdings
- Multiple RSU grants vesting over time could result in future increases to share count attributable to the insider
Insights
TL;DR: Insider sale of 13,084 shares reduces CEO stake but he retains a substantial position (286,293 shares); sale prices ranged $49.16–$49.55.
The transaction is a routine disclosure of an insider sale rather than an equity issuance or option exercise. The weighted-average sale price of $49.3566 and the disclosed price range provide transparency on execution. The remaining beneficial ownership of 286,293 shares, including multiple RSU grants with staggered vesting dates, indicates continued alignment with shareholders while scheduling future compensation vesting. No options or derivative activity was reported, limiting complexity.
TL;DR: A director/CEO executed open-market sales totaling 13,084 shares and remains a major insider holder with RSUs vesting over coming years.
The Form 4 documents an open-market disposition by the CEO and director, accompanied by clear footnote disclosure of a weighted-average price and the price range. The filing lists multiple RSU grants with explicit vesting schedules, which is important for assessing future insider dilution and retention incentives. The filing is procedural and compliant in form; it does not indicate unusual governance events such as accelerated vesting or transfers to affiliates.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common stock, par value $0.01 per share | 13,084 | $49.3566 | $646K |
Footnotes (1)
- The price reported is a weighted average. The shares were sold in multiple transactions at prices ranging from $49.16 to $49.55. Upon request, the reporting person will provide the SEC, the company, or any stockholder full information regarding the number of shares sold at each separate price in the range. Includes 4,364 restricted stock units that vest in three equal installments on July 29, 2026, 2027, and 2028. Includes 14,420 restricted stock units that vest in three equal installments on February 15, 2026, 2027, and 2028. Includes 3,750 restricted stock units. The original grant of 15,000 restricted stock units vests in four equal installments on December 17, 2022, 2023, 2024, and 2025. Includes 10,991 restricted stock units. The original grant of 16,486 restricted stock units vests in three equal installments on February 15, 2025, 2026, and 2027. Includes 6,768 restricted stock units. The original grant of 20,302 restricted stock units vests in three equal installments on February 15, 2024, 2025, and 2026.